Search

everythinglearnresearchcommunity

for

Search:↓

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Metabolites and diet affect hair growth cycles in cashmere goats.

Enzymes involved in Vitamin A metabolism affect hair growth and type in mice.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.

Chromosomal differences affect how muscle cells respond to testosterone.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

More research is needed to understand how testosterone is maintained in adult males.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Immune cells are crucial for hair growth and preventing hair loss.

Hormones and stretching both needed for nipple area skin growth in mice.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.